Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Pediatr Blood Cancer. 2023 Feb 15;70(5):e30251. doi: 10.1002/pbc.30251

Figure 2. Oncoprint illustrating fusions present in pediatric AMKL, and their co-operating cytogenetic abnormalities and mutations.

Figure 2.

The abnormalities present in chr13 (Abn13) include del(13q), monosomy 13, trisomy 13, and chr13 translocations. Additional cytogenetic aberrations reported are copy number variations (trisomy 3, trisomy 6, monosomy 7/del7q, and monosomy5/del5q).